Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03634579 · ClinicalTrials.gov registry record · NA
MRI Guided Prostate Cancer Focal Laser Ablation
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03634579 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 9 participants.
The verdict
NCT03634579, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The study is a prospective, single-arm, non-randomized, unblinded trial to determine the safety and efficacy of MRI guided focal laser ablation of localized low and intermediate risk prostate cancer. All subjects meeting the inclusion exclusion criteria and are enrolled will undergo a MRI guided focal laser ablation procedure. The primary aim of the study is to study the safety and efficacy of the procedure.
Interventions
- DEVICE MRI Guided Focal Laser Interstitial Thermal Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2019-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03634579
The ClinicalTrials.gov registry entry for NCT03634579 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI Guided Focal Laser Interstitial Thermal Ablation is the first listed.
NCT03634579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03634579 about?
NCT03634579 is a clinical study titled "MRI Guided Prostate Cancer Focal Laser Ablation". The study is a prospective, single-arm, non-randomized, unblinded trial to determine the safety and efficacy of MRI guided focal laser ablation of localized low and intermediate risk prostate cancer. All subjects meeting the inclusion exclusion criteria and are enrolled will undergo a MRI guided foc...
What is the current status of trial NCT03634579?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2018-06-01. Estimated completion is 2019-03-15.
What interventions are being tested in trial NCT03634579?
The interventions under investigation include: MRI Guided Focal Laser Interstitial Thermal Ablation (DEVICE).
Who is sponsoring clinical trial NCT03634579?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.